LSU Health Shreveport chooses Digital Science to support Research Discovery and Integrity (opens in new window/tab)
March Biosciences and Cancer Focus Fund Announce $4.8 Million Investment to Support a Phase 2 Clinical Trial of Novel CAR-T Therapy for T-Cell Lymphoma (opens in new window/tab)